| Description |
1 online resource (286 pages) |
| Contents |
Intro; Title Page; Copyright Page; Contents; List of Contributors; Foreword by Prof. W. Hoffmann; Foreword by Prof. G. Mehta; Preface; Chapter 1 Introduction: Concepts, History, Need, and Future Prospects of Protecting-Group-Free Synthesis; 1.1 Introduction, Concepts, and Brief History; 1.2 Need and Future Prospects of Protecting-Group-Free Synthesis; References; Chapter 2 Protecting-Group-Free Synthesis of Natural Products and Analogs, Part I; 2.1 Introduction; 2.2 Mytilipin A; 2.3 Chokols; 2.4 (±)-Diospongin A; 2.5 (−)-Bitungolide F; 2.6 (+)-Brevisamide; 2.7 21,22-Diepi-membrarolin |
|
2.8 (±)-Pogostol and (±)-Kessane2.9 (+)-Allopumiliotoxin 267A; 2.10 (−)-Hortonones A-C; 2.11 (−)-Heliophenanthrone; 2.12 (−)-Pycnanthuquinone C; 2.13 (+)-Aplykurodinone-1; 2.14 (±)-Hippolachnin A; 2.15 (+)-Linoxepin; 2.16 (+)-Antofine and (-)-Cryptopleurine; 2.17 (+)-Tylophorine; 2.18 (±)-Cruciferane; 2.19 (+)-Artemisinin; 2.20 (±)-Dievodiamine; 2.21 (−)-Chaetominine; 2.22 Rubicordifolin; 2.23 (+)-Caribenol A; 2.24 Camptothecin and 10-Hydroxycamptothecin; 2.25 (+)-Ainsliadimer A; 2.26 Cannabicyclol, Clusiacyclols A and B, Iso-Eriobrucinols A and B, and Eriobrucinol |
|
2.27 (−)-Mersicarpine, (−)-Scholarisine G, (+)-Melodinine, (−)-Leuconoxine, and (−)-Leuconolam2.28 (−)-Lannotinidine B; 2.29 (−)-Lycopodine; 2.30 (−)-Lycospidine A; 2.31 Transtaganolides C and D; 2.32 (+)-Chatancin; 2.33 (−)-Jiadifenolide; 2.34 Pallambins C and D; 2.35 (+)-Vellosimine; 2.36 (−)-Pallavicinin and (+)-Neopallavicinin; 2.37 Asteriscunolides A-D and Asteriscanolide; 2.38 (−)- and (+)-Palmyrolide A; 2.39 (±)-Bipinnatin J; 2.40 Cyanolide; 2.41 Conclusions; References; Chapter 3 Protecting-Group-Free Synthesis of Natural Products and Analogs, Part II; 3.1 Introduction |
|
3.2 Hapalindole U and Ambiguine H3.3 Stenine; 3.4 Neostenine; 3.5 Englerin A; 3.6 Shimalactones A and B; 3.7 Cyanthiwigin F; 3.8 Sintokamides A, B, and E; 3.9 Ecklonialactones A and B; 3.10 (E)- and (Z)-Alstoscholarines; 3.11 Berkelic Acid; 3.12 Myxalamide A; 3.13 Pipercyclobutanamide A; 3.14 Fusarisetin A; 3.15 Rhazinilam; 3.16 Yezo'otogirin C; 3.17 Clavosolide A; 3.18 Conclusion; References; Chapter 4 Protecting-Group-Free Synthesis of Natural Products and Analogs, Part III; 4.1 Introduction; 4.2 Syntheses of Naturally Occurring Alkaloids; 4.3 Syntheses of Naturally Occurring Terpenoids |
|
4.4 ConclusionsReferences; Chapter 5 Protecting-Group-Free Synthesis of Heterocycles; 5.1 Introduction; 5.2 Historical Background of Protection-Free Strategy; 5.3 Protecting-Group-Free (PGF) Strategy for the Synthesis of N-Heterocycles; 5.3.1 Carbazole Substituted Compounds Using PGF Strategy; 5.3.2 Protection-Free Synthesis of Indole-Substituted Compounds; 5.3.3 Synthesis of Pyrrole Analogs Using Protecting-Group-Free Strategy; 5.4 Protection-Free Synthesis of Quinoline Derivatives; 5.5 Synthesis of Piperidine-Containing Heterocycles Without Using Protecting Groups |
| Notes |
5.6 Synthesis of Quinazolines Without Using Protecting Groups |
|
Print version record |
| Subject |
Organic compounds -- Synthesis.
|
|
Organic compounds -- Synthesis
|
| Form |
Electronic book
|
| ISBN |
9781119295228 |
|
111929522X |
|
